UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Price cut, expanded indication to prop up cholesterol-reducing PCSK9 inhibitors
Physicians are likely to use cholesterol-lowering proprotein convertase sub...
by Kim Yun-mi
|
2019-02-13 16:11
라인
Mediforum gets ₩19 billion investment
Mediforum said Wednesday that it has received investment worth 19 billion w...
by Lee Han-soo
|
2019-02-13 15:19
라인
Genexine, SCM Life Science acquire Argos Therapeutics
Genexine and SCM Life Science said Wednesday that they took over Argos Ther...
by Lee Han-soo
|
2019-02-13 15:17
라인
CJ Healthcare to export gastroesophageal reflux treatment to Latin America
CJ Healthcare said Wednesday that it has signed a licensing agreement for K...
by Lee Han-soo
|
2019-02-13 10:50
라인
GC posts ₩1.3 trillion in 2018 sales
GC said Wednesday that it has recorded 1.3 trillion won ($1.1 billion) in s...
by Lee Han-soo
|
2019-02-13 10:50
라인
Bridge Biotherapeutics unveils clinical trials results for ulcerative colitis treatment
Bridge Biotherapeutics said it presented the preclinical and phase 1 study ...
by Lee Han-soo
|
2019-02-12 17:38
라인
AbbVie’s new hepatitis C treatment outpaces Gilead’s rival drugs
AbbVies’s new hepatitis C therapy Mavyret (glecaprevir/pibrentasvir), a fol...
by Kim Yun-mi
|
2019-02-12 15:56
라인
Pfizer Korea voluntarily recalls antibiotic Zyvox
Pfizer Korea said it voluntarily recalled some of Zyvox 600mg (ingredient: ...
by Lee Hye-seon
|
2019-02-12 15:56
라인
SK Chemical to co-promote Janssen’s dementia treatment
SK Chemical said Tuesday that it has signed an agreement with Janssen Korea...
by Lee Han-soo
|
2019-02-12 15:55
라인
Demands for MMR vaccines spike amid resurgence of measles
Amid a rise of measles patients, clinics are suffering a shortage of MMR (m...
by Park Gi-taek
|
2019-02-12 11:19
라인
IVI to cooperate with CEPI to develop vaccines
International Vaccine Institute (IVI) said it has signed a partner service ...
by Lee Han-soo
|
2019-02-11 16:41
라인
Gilead’s hepatitis B drug posts disappointing sales in 2018
Gilead Sciences Korea’s hepatitis B treatment Vemlidy (ingredient: tenofovi...
by Kim Yun-mi
|
2019-02-11 15:29
라인
Sales of antidiabetic SGLT-2 inhibitors expand 40% in 2018
Sales of antidiabetic drugs using sodium-glucose cotransporter 2 (SGLT-2) i...
by Kim Yun-mi
|
2019-02-11 14:35
라인
Novo Nordisk has high expectations for GLP-1 receptor agonists
Novo Nordisk is confident that 2019 will be another good business year ridi...
by Kim Yun-mi
|
2019-02-08 17:11
라인
Bioneer’s HIV diagnostic kit registered on Global Fund’s purchase list
Bioneer said its human immunodeficiency virus type 1 (HIV-1) diagnostic kit...
by Park Gi-taek
|
2019-02-08 16:46
라인
Pangen wins Malaysia’s nod for epoetin alfa biosimilar
Pangen said Thursday that Malaysia’s National Pharmaceutical Regulatory Age...
by Lee Han-soo
|
2019-02-08 16:13
라인
Sanofi seeks to add cholesterol-lowering drug’s new indication in Korea
Sanofi is preparing to seek an additional indication of Praluent (alirocuma...
by Kim Yun-mi
|
2019-02-08 16:12
라인
Multinationals prepare next-generation pneumococcal vaccines
Multinational pharmaceutical firms are gearing up to replace conventional p...
by Kim Yun-mi
|
2019-02-08 12:02
라인
Kainos Medicine starts developing treatment for multiple system atrophy
Kainos Medicine said Friday that it would develop a treatment for multiple ...
by Lee Han-soo
|
2019-02-08 11:47
라인
‘Novartis’ Cosentyx, a cost-effective alternative to Humira’
Novartis said Thursday that Cosentyx (Ingredient: secukinumab), its interle...
by Lee Han-soo
|
2019-02-07 17:14
-
이전
51
52
53
54
55
56
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top